Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs

Research output: Contribution to journal › Article › peer-review

Abstract

Work published in Statistics in Biopharmaceutical Research .

Original language	American English
Journal	Statistics in Biopharmaceutical Research
State	Published - Jan 1 2020

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{d87456303ca443e9be0f5943b21b7f32,

title = "Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs",

abstract = " Work published in Statistics in Biopharmaceutical Research .",

author = "Qing Liu and Peace, {Karl E.}",

year = "2020",

month = jan,

day = "1",

language = "American English",

journal = "Statistics in Biopharmaceutical Research",

issn = "1946-6315",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs

AU - Liu, Qing

AU - Peace, Karl E.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Work published in Statistics in Biopharmaceutical Research .

AB - Work published in Statistics in Biopharmaceutical Research .

UR - https://digitalcommons.georgiasouthern.edu/bee-facpubs/244

M3 - Article

SN - 1946-6315

JO - Statistics in Biopharmaceutical Research

JF - Statistics in Biopharmaceutical Research

ER -